Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

Date : 12/19/2011 @ 2:02AM
Source : Dow Jones News
Stock : Valeant Pharmaceuticals International, Inc. (VRX)
Quote : 8.51  0.0 (0.00%) @ 9:06AM

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

Sanofi (EU:SAN)
Historical Stock Chart

5 Years : From Apr 2012 to Apr 2017

Click Here for more Sanofi Charts.

French drug company Sanofi-Aventis (SAN.FR) announced Monday the finalization of the sale of its Canadian dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (VRX) for $422.5 million.

In a statement, Sanofi said the transaction includes an aesthetic and therapeutic business in the U.S. and Canada, as well as an aesthetic business around the world.

Sanofi's Canadian unit will continue its operations in Greater Montreal, said the company.

-By Nadya Masidlover, Dow Jones Newswires; +33 1 4017 1740; nadya.masidlover@dowjones.com




Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.